Author

Parisa Ghahremanifard

National Institute of Genetic Engineering and BiotechnologyORCID 0000-0002-6583-5047Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Bioinformatics· 1 Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Organism:human· 2 Approach:statistical model· 2 Assay:bulk RNA-seq· 1 Research Focus:cell type annotation· 1 Research Focus:differential expression· 1 Research Focus:drug response / drug discovery· 1 Assay:proteomics· 1 Assay:scRNA-seq· 1

Frequent Co-Authors

Amin Rostami· 1 shared Angela M. Y. ChaniD· 1 shared Anusi SarkariD· 1 shared Ayan ChandaiD· 1 shared Bijan BambaiiD· 1 shared Doha Itani· 1 shared Farzaneh AfzaliiD· 1 shared J. AniD· 1 shared

Activity by Year

2019-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 24 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperBioinformatics

Amin Rostami

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

PIAS1 loss and INHBA gain define a TGFβ-driven EMT state in OSCC progression

Ayan Chanda, Parisa Ghahremanifard, J. An, Rohit Arora, Anusi Sarkar, Angela M. Y. Chan, Doha Itani, Steven C. Nakoneshny, Thomas Wayne Matthews, Shamir P. Chandarana, Robert D. Hart, Joseph C. Dort, Martin D. Hyrcza, Shirin Bonni, Pinaki Bose

This study identifies PIAS1 loss and INHBA gain as drivers of TGFβ-induced EMT in OSCC, linking them to poor prognosis and therapeutic resistance.

bioRxiv · Sep 22, 2026 · PreprintCancer Biology

Designing a novel multi-epitope T vaccine for \"targeting protein for Xklp-2\" (TPX2) in hepatocellular carcinoma based on immunoinformatics approach

Parisa Ghahremanifard, Farzaneh Afzali, Amin Rostami, Zahra Nayeri, Bijan Bambai, Zarrin Minuchehr

This study designs a multi-epitope T vaccine targeting TPX2 in HCC using immunoinformatics tools, showing stability, immunogenicity, and potential for TLR4 activation.

International Journal of Peptide Research and Therapeutics · Aug 26, 2019Peer-reviewedBioinformatics